Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Tasmin Farzana"'
Autor:
Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura, Sean M. Devlin, Tasmin Farzana, Sridevi Rajeeve, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Alexander M. Lesokhin, Urvi A. Shah, Carlyn R. Tan, Sergio A. Giralt, Saad Z. Usmani, Karthik Nath, Sham Mailankody
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Despite being the mainstay of management for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), there is limited data regarding the impact of tocilizumab (TCZ) and corticosteroids (CCS) on chi
Externí odkaz:
https://doaj.org/article/b0599253316a411c8f7c1eb08d801e0c
Autor:
Karthik Nath, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Bruno Almeida Costa, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Neha Korde, Urvi A. Shah, Carlyn Rose Tan, Malin Hultcrantz, Sergio A. Giralt, Saad Z. Usmani, Zainab Shahid, Sham Mailankody, Alexander M. Lesokhin
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this retrospective, single-center analysis we evaluated infectious complications after BCMA-targ
Externí odkaz:
https://doaj.org/article/6b93aedeb2774601928a329b4bbfda19
Autor:
Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T. Melnekoff, Yogita Ghodke-Puranik, Gunjan L. Shah, Alexander Lesokhin, Sergio Giralt, Santiago Thibaud, Adriana Rossi, Cesar Rodriguez, Larysa Sanchez, Joshua Richter, Shambavi Richard, Hearn J. Cho, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Urvi A. Shah, Sham Mailankody, Samir Parekh
Publikováno v:
Blood. 141:756-765
B-cell maturation antigen (BCMA)–directed chimeric antigen receptor T-cell (CAR T) therapy has demonstrated remarkable efficacy in patients with relapsed/refractory multiple myeloma, and now there are two US Food and Drug Administration–approved
Autor:
Oliver, Van Oekelen, Karthik, Nath, Tarek H, Mouhieddine, Tasmin, Farzana, Adolfo, Aleman, David T, Melnekoff, Yogita, Ghodke-Puranik, Gunjan L, Shah, Alexander M, Lesokhin, Sergio A, Giralt, Santiago, Thibaud, Adriana, Rossi, Cesar, Rodriguez, Larysa, Sanchez, Joshua, Richter, Shambavi, Richard, Hearn Jay, Cho, Ajai, Chari, Saad Z, Usmani, Sundar, Jagannath, Urvi A, Shah, Sham, Mailankody, Samir, Parekh
Publikováno v:
Blood.
B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell therapy (CAR T) has demonstrated remarkable efficacy in patients with relapsed/refractory multiple myeloma, and there are now two FDA-approved BCMA-directed CAR T products. Ho
Autor:
Sham Mailankody, Sean M. Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J. Carstens, Douglas Russo, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xiuyan Wang, Devanjan Sikder, Brigitte Senechal, Vladimir P. Bermudez, Terence J. Purdon, Kinga Hosszu, Devin P. McAvoy, Tasmin Farzana, Elena Mead, Jessica A. Wilcox, Bianca D. Santomasso, Gunjan L. Shah, Urvi A. Shah, Neha Korde, Alexander Lesokhin, Carlyn R. Tan, Malin Hultcrantz, Hani Hassoun, Mikhail Roshal, Filiz Sen, Ahmet Dogan, Ola Landgren, Sergio A. Giralt, Jae H. Park, Saad Z. Usmani, Isabelle Rivière, Renier J. Brentjens, Eric L. Smith
Publikováno v:
N Engl J Med
BACKGROUND: B-cell maturation antigen (BCMA)–directed chimeric antigen receptor (CAR) T-cell therapies have generated responses in patients with advanced myeloma, but relapses are common. G protein–coupled receptor, class C, group 5, member D (GP
Autor:
Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T. Melnekoff, Yogita Ghodke-Puranik, Sundar Jagannath, Urvi A. Shah, Sham Mailankody, Samir Parekh
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S428
Autor:
Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T. Melnekoff, Yogita Ghodke-Puranik, Sundar Jagannath, Urvi A. Shah, Sham Mailankody, Samir Parekh
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S184
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vijenthira, Shangari *, Saeed, Samia *, Zhang, Liying *, Siddiqui, Reda *, Massin, Sophia *, Armali, Chantal *, Kron, Amie *, Hajjaj, Omar *, Rashedi, Iran *, Meirovich, Harley *, Tasmin, Farzana *, Abdulwabab, Widad *, Manswell, Lisa *, Ilagan, Cesario *, Pendergrast, Jacob, Lieberman, Lani *, Branch, Donald R. *, Khandelwal, Aditi, Shehata, Nadine, Pavenski, Katerina, Lin, Yulia, Callum, Jeannie L, Cserti-Gazdewich, Christine M.
Publikováno v:
In Blood 15 November 2022 140 Supplement 1:2829-2830
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.